Literature DB >> 29177767

Membrane Aging as the Real Culprit of Alzheimer's Disease: Modification of a Hypothesis.

Qiujian Yu1, Chunjiu Zhong2.   

Abstract

Our previous studies proposed that Alzheimer's disease (AD) is a metabolic disorder and hypothesized that abnormal brain glucose metabolism inducing multiple pathophysiological cascades contributes to AD pathogenesis. Aging is one of the great significant risk factors for AD. Membrane aging is first prone to affect the function and structure of the brain by impairing glucose metabolism. We presume that risk factors of AD, including genetic factors (e.g., the apolipoprotein E ε4 allele and genetic mutations) and non-genetic factors (such as fat, diabetes, and cardiac failure) accelerate biomembrane aging and lead to the onset and development of the disease. In this review, we further modify our previous hypothesis to demonstrate "membrane aging" as an initial pathogenic factor that results in functional and structural alterations of membranes and, consequently, glucose hypometabolism and multiple pathophysiological cascades.

Entities:  

Keywords:  Alzheimer’s disease; Amyloid-β; Membrane aging; Thiamine

Mesh:

Year:  2017        PMID: 29177767      PMCID: PMC5856718          DOI: 10.1007/s12264-017-0192-4

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  153 in total

1.  Generation of Alzheimer disease-associated amyloid β42/43 peptide by γ-secretase can be inhibited directly by modulation of membrane thickness.

Authors:  Edith Winkler; Frits Kamp; Johannes Scheuring; Amelie Ebke; Akio Fukumori; Harald Steiner
Journal:  J Biol Chem       Date:  2012-04-24       Impact factor: 5.157

2.  Regulation of drugs for early Alzheimer's disease.

Authors:  Donald W Light; Jonathan Darrow
Journal:  N Engl J Med       Date:  2013-07-18       Impact factor: 91.245

3.  Disentangling normal aging from Alzheimer's disease in structural magnetic resonance images.

Authors:  Marco Lorenzi; Xavier Pennec; Giovanni B Frisoni; Nicholas Ayache
Journal:  Neurobiol Aging       Date:  2014-09-06       Impact factor: 4.673

4.  Omega-3 fatty acid obtained from Nannochloropsis oceanica cultures grown under low urea protect against Abeta-induced neural damage.

Authors:  Ying-Jang Lai
Journal:  J Food Sci Technol       Date:  2014-04-23       Impact factor: 2.701

5.  Specific and non specific stimulation of prostaglandin release by human skin fibroblasts in culture.--Are changes of membrane fluidity involved?

Authors:  V Baciulis; C Luthy; G Hofer; H Toplak; U N Wiesmann; O H Oetliker
Journal:  Prostaglandins       Date:  1992-03

6.  Disturbance of redistribution of surface membrane receptors on peripheral mononuclear cells of patients with Down's syndrome and of aged individuals.

Authors:  F Naeim; R L Walford
Journal:  J Gerontol       Date:  1980-09

7.  Altered calcium metabolism in aging CA1 hippocampal pyramidal neurons.

Authors:  M Matthew Oh; Fernando A Oliveira; Jack Waters; John F Disterhoft
Journal:  J Neurosci       Date:  2013-05-01       Impact factor: 6.167

8.  Secretory phospholipase A2 type III enhances alpha-secretase-dependent amyloid precursor protein processing through alterations in membrane fluidity.

Authors:  Xiaoguang Yang; Wenwen Sheng; Yan He; Jiankun Cui; Mark A Haidekker; Grace Y Sun; James C-M Lee
Journal:  J Lipid Res       Date:  2009-10-05       Impact factor: 5.922

9.  Non-electrostatic binding and self-association of amyloid beta-peptide on the surface of tightly packed phosphatidylcholine membranes.

Authors:  Mayumi Yoda; Takashi Miura; Hideo Takeuchi
Journal:  Biochem Biophys Res Commun       Date:  2008-08-26       Impact factor: 3.575

Review 10.  "Down syndrome: an insight of the disease".

Authors:  Ambreen Asim; Ashok Kumar; Srinivasan Muthuswamy; Shalu Jain; Sarita Agarwal
Journal:  J Biomed Sci       Date:  2015-06-11       Impact factor: 8.410

View more
  3 in total

1.  TDP-43-Mediated Toxicity in HEK293T Cells: A Fast and Reproducible Protocol To Be Employed in the Search of New Therapeutic Options against Amyotrophic Lateral Sclerosis.

Authors:  Débora Lanznaster; Jérôme Bourgeais; Clement Bruno; Rudolf C Hergesheimer; Rose-Anne Thepault; Patrick Vourc'h; Philippe Corcia; Christian R Andres; Olivier Herault; Hélène Blasco
Journal:  Cells       Date:  2019-12-26       Impact factor: 6.600

Review 2.  Lipids in Pathophysiology and Development of the Membrane Lipid Therapy: New Bioactive Lipids.

Authors:  Manuel Torres; Sebastià Parets; Javier Fernández-Díaz; Roberto Beteta-Göbel; Raquel Rodríguez-Lorca; Ramón Román; Victoria Lladó; Catalina A Rosselló; Paula Fernández-García; Pablo V Escribá
Journal:  Membranes (Basel)       Date:  2021-11-24

3.  Clinical efficacy of sertraline in the treatment of depression caused by Alzheimer disease: A protocol of systematic review.

Authors:  Wei-Hua Li; Zhuo-Wen Wei; Xiao-Feng Liu
Journal:  Medicine (Baltimore)       Date:  2020-11-06       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.